Use of Mustela Stelatopia moisturising products in children with atopic dermatitis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

THE AIM OF THE STUDY WAS To estimate the efficiency and tolerance of daily application of Mustela Stelatopia emollient cream and bath oil as products for care of child's skin in 64 children suffering from atopic dermatitis. Results. The study showed that Mustela Stelatopia had a considerable treatment-and-prophylactic effects resulted to lower dryness and reduced itching. Skin humidity and SCORAD index during the study had expressed positive dynamics in children of the basic group unlike the comparison group

About the authors

V A Revyakina

НИИ питания РАМН

Email: 5356797@mail.ru
НИИ питания РАМН

A T Surkov

НИИ питания РАМН

НИИ питания РАМН

S T Makarova

НИИ питания РАМН

НИИ питания РАМН

I I Balabolkin

НИИ питания РАМН

НИИ питания РАМН

V A Revyakina

A G Surkov

References

  1. Ellis C., Luger T, Abeck D. et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br. J. Dermatol. 2003, v. 148, Suppl 63, p. 3-10.
  2. Hara J., Higuchi K., Okamoto R. Decreased levels of ceramides in involved and uninvolved skin of patients with AD. J. Invest Dermatol. 2000, v. 115, p. 406-413.
  3. Di Nardo A., Wertz P., Giannetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis Acta Derm. Venereol. 1998, v. 78 (1), p. 27-30.
  4. Ohnishi Y, Okino N., Ito M., Imayama S. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis. Clin. Diagn. Lab. Immunol. 1999, v. 6, p. 101-454.
  5. Elias P.M., Wood L.C., Feingold K.R. Epidermal pathogenesis of inflammatory dermatoses. Am. J. Contact. Dermat. 1999, v. 10, p. 119-126.
  6. Murata Y., Ogata J., Higaki Y, Kawashima M. et al. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J. Invest. Dermatol. 1996, v. 106 (6), p. 1242-1249.
  7. Fartasch M. Epidermal barrier in disorders of the skin. Microsc. Res. Tech. 1997, v. 38 (4), p. 361-372.

Copyright (c) 1970 Pharmarus Print Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies